Who profits from insulin?

December 4, 2021

Medicare is running a pilot program capping the monthly cost of insulin, but there is no federal regulation in sight. In the absence of federal leadership, eight states have capped monthly insulin costs at between $30 and $100. “The pharmaceutical pricing system is just rigged, and it’s rigged so patients pay more each year. Competition does not drive prices down.” Senator Ron Wyden of Oregon.

Read the source article at News Break
2021-11-19 15:00:00

Share This Story!